DDD exit financed with 68 MSEK to develop novel cancer therapy

In June 2022, Marika Nestor’s project aiming to develop a novel cancer therapy left the DDD Platform at SciLifeLab. Six months later, the resulting spin-out company Akiram Therapeutics raised 68 … Continue reading DDD exit financed with 68 MSEK to develop novel cancer therapy